ICM
MRK icon

IMS Capital Management’s Merck MRK Stock Holding History

IMS Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$808K Sell
9,632
-1,479
-13% -$122K 0.37% 67
2025
Q2 		$880K Sell
11,111
-1,060
-9% -$84.3K 0.41% 60
2025
Q1 		$1.09M Sell
12,171
-461
-4% -$43K 0.55% 55
2024
Q4 		$1.26M Sell
12,632
-2,108
-14% -$217K 0.58% 48
2024
Q3 		$1.67M Buy
14,740
+2,200
+18% +$261K 0.75% 40
2024
Q2 		$1.44M Sell
12,540
-346
-3% -$44.6K 0.67% 43
2024
Q1 		$1.7M Sell
12,886
-118
-0.9% -$14.5K 0.79% 39
2023
Q4 		$1.42M Sell
13,004
-123
-0.9% -$12.8K 0.7% 42
2023
Q3 		$1.35M Buy
13,127
+2
+0% +$216 0.81% 35
2023
Q2 		$1.51M Sell
13,125
-193
-1% -$21.9K 0.84% 34
2023
Q1 		$1.42M Sell
13,318
-2,298
-15% -$248K 0.84% 33
2022
Q4 		$1.73M Buy
15,616
+2,302
+17% +$235K 1.1% 25
2022
Q3 		$1.15M Sell
13,314
-2,833
-18% -$253K 0.79% 34
2022
Q2 		$1.47M Buy
16,147
+2,704
+20% +$240K 0.95% 25
2022
Q1 		$1.1M Buy
13,443
+352
+3% +$27.8K 0.58% 49
2021
Q4 		$1M Buy
13,091
+978
+8% +$77.9K 0.52% 55
2021
Q3 		$910K Buy
12,113
+737
+6% +$56.1K 0.53% 53
2021
Q2 		$885K Sell
11,376
-963
-8% -$71.6K 0.52% 52
2021
Q1 		$908K Buy
12,339
+139
+1% +$10.3K 0.57% 49
2020
Q4 		$952K Sell
12,200
-260
-2% -$19.9K 0.59% 45
2020
Q3 		$986K Sell
12,460
-2,094
-14% -$164K 0.71% 39
2020
Q2 		$1.07M Buy
14,554
+1,653
+13% +$124K 0.83% 26
2020
Q1 		$947K Buy
12,901
+505
+4% +$39.7K 0.96% 23
2019
Q4 		$1.08M Buy
12,396
+2
+0% +$164 0.74% 28
2019
Q3 		$996K Buy
12,394
+317
+3% +$25.4K 0.76% 30
2019
Q2 		$966K Buy
12,077
+609
+5% +$46.6K 0.72% 42
2019
Q1 		$910K Sell
11,468
-3,407
-23% -$255K 0.74% 45
2018
Q4 		$1.08M Buy
14,875
+3,174
+27% +$224K 1.02% 27
2018
Q3 		$792K Buy
11,701
+90
+0.8% +$5.73K 0.54% 51
2018
Q2 		$672K Buy
11,611
+1,237
+12% +$69.8K 0.43% 64
2018
Q1 		$557K Hold
10,374
– – 0.34% 79
2017
Q4 		$557K Sell
10,374
-858
-8% -$47.6K 0.34% 79
2017
Q3 		$686K Sell
11,232
-208
-2% -$12.6K 0.44% 72
2017
Q2 		$700K Buy
11,440
+246
+2% +$15K 0.66% 71
2017
Q1 		$679K Buy
11,194
+694
+7% +$42.1K 0.68% 59
2016
Q4 		$590K Buy
10,500
+1,155
+12% +$67.6K 0.63% 62
2016
Q3 		$557K Sell
9,345
-105
-1% -$6.14K 0.64% 57
2016
Q2 		$519K Buy
9,450
+1,216
+15% +$64.7K 0.61% 60
2016
Q1 		$416K Sell
8,234
-10,664
-56% -$522K 0.5% 64
2015
Q4 		$952K Sell
18,898
-372
-2% -$18.8K 1.17% 31
2015
Q3 		$908K Buy
19,270
+15,209
+375% +$808K 1.09% 36
2015
Q2 		$221K Buy
4,061
+79
+2% +$4.43K 0.26% 119
2015
Q1 		$218K Buy
+3,982
New +$225K 0.24% 127

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

IMS Capital Management's MRK Position: Q3 2025 in Review

IMS Capital Management reduced its Merck (MRK) stake by 13% in Q3 2025, selling an estimated $122K and leaving 9,632 shares worth $808K. The position accounts for 0.37% of the portfolio, ranked #67.

IMS Capital Management first reported a position in MRK in Q1 2015 and has held it in 43 quarters since. The position peaked at $1.73M in Q4 2022. 3,310 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • IMS Capital Management held 9,632 shares of Merck worth $808K as of Q3 2025.
  • IMS Capital Management sold 1,479 Merck shares in Q3 2025, an estimated $122K.
  • Merck made up 0.37% of IMS Capital Management's portfolio in Q3 2025, its #67 holding.
  • IMS Capital Management first reported a position in Merck in Q1 2015 and has held it in 43 quarters since.
  • IMS Capital Management's Merck position peaked at $1.73M in Q4 2022.
  • 3,310 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on IMS Capital Management's 13F filing for Q3 2025, filed 17 Nov 2025.